Lung cancer trials and health studies reported

· 8 source(s)

Short summary

Medical Xpress reports phase 3 trial results presented at the IASLC 2026 World Conference on Lung Cancer. The SWOG S1827 MAVERICK trial found MRI surveillance alone improved cognitive failure-free survival versus MRI plus prophylactic cranial irradiation in small-cell lung cancer. The HARMONi-2 trial reported ivonescimab prolonged overall survival versus pembrolizumab in PD-L1-positive advanced non-small cell lung cancer. The ARTEMIS-008 and TAISHAN-302 trials reported survival improvements for antibody-drug conjugates in relapsed small-cell lung cancer, while EVOKE-03/KEYNOTE-D46 did not meet

Mind map

Health research updates

Drag to pan · pinch or the + / − buttons to zoom · swipe up or down to scroll the page.

Read the map as an outline
  • Small-cell lung cancer trials
    • MRI surveillance alone improved cognitive failure-free survival
    • Ris-Rez improved overall survival vs topotecan
    • Tam-Peli improved survival vs topotecan
  • Non-small cell lung cancer trials
    • Ivonescimab prolonged survival vs pembrolizumab
    • SG plus pembrolizumab missed primary endpoints
  • Vision research
    • Perception test predicts laser blended vision success
  • Embryo gene editing research
    • DNA repair studied in early human embryos
  • ADHD and autism study
    • Diagnosed profiles changed over past decade

Map your own version

This post is a mind map of what today's sources reported. Start with a blank canvas and build the same thing for whatever you are working on — it opens straight away, no account needed until you want to keep it.

Try it as a mind map → Or start from a template

Sources

Written by an AI model from the sources listed above, then published without edits. It summarises what those sources reported and adds nothing of its own — for the full story, follow the links. Model: deepseek-chat.

More health